Erhalten Sie eine woechentliche Zusammenfassung der neuesten psychedelischen Forschung, neuer Studien und Plattform-Updates direkt in Ihren Posteingang.
Kein Spam, nie. Jederzeit abbestellbar.
Rechtsstatus psychedelischer Substanzen nach Land
Diese Informationen dienen nur zu Bildungszwecken und spiegeln moglicherweise nicht den aktuellsten Rechtsstatus wider. Prufen Sie immer offizielle Regierungsquellen.
Abgedeckte Lander
30
Lander mit legalem Zugang
16
Medizinische Ausnahmen
28
Aktive Forschung
19
Oregon: legal (supervised, 2023), Colorado: decriminalized (2022), FDA Breakthrough Therapy designation
FDA Breakthrough Therapy for PTSD, NDA submitted 2023
Esketamine (Spravato) FDA-approved for TRD (2019)
No active policy changes
UDV and Santo Daime religious exemptions (Supreme Court 2006)
No exceptions
Section 56 exemptions for end-of-life, Special Access Programme since 2022
Special Access Programme
Off-label use for depression widespread
Section 56 exemptions available
Section 56 exemptions; ayahuasca retreats in legal gray area
Legal, ibogaine clinics operate openly
Not explicitly illegal, gray area
Research only
Medical use approved, off-label depression treatment growing
Legal for religious use since 2010 (CONAD resolution)
Ibogaine clinics operate; not explicitly prohibited
Traditional/indigenous use tolerated; Mazatec ceremonies in Oaxaca
No exceptions
Medical use, growing off-label depression treatment
Ceremonial use tolerated
Legal; major destination for ibogaine treatment centers
Not explicitly prohibited; mushrooms grow naturally
Protected as indigenous cultural heritage; retreat industry
Medical use approved
Legal — not in the Dangerous Drugs Act. Retreat centers operate openly
No exceptions
Medical use only
Traditional use in Andean ceremonies tolerated
Declared cultural patrimony (2008); major ayahuasca retreat destination
Not regulated
Not explicitly prohibited; retreat centers operate
Retreat centers operate in legal gray area
Treatment centers operate openly